- Home
- ONON vs ICLR Comparison
ONON vs ICLR Comparison
Compare ONON & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONON | ICLR |
|---|---|---|
| Founded | 2010 | 1990 |
| Country | Switzerland | Ireland |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 14.3B |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ONON | ICLR |
|---|---|---|
| Price | $48.93 | $189.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $62.57 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 7.0M | 1.0M |
| Earning Date | 11-12-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.51 | N/A |
| EPS | 0.84 | ★ 7.47 |
| Revenue | $3,607,815,596.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $31.86 | N/A |
| Revenue Next Year | $22.90 | $0.76 |
| P/E Ratio | $58.62 | ★ $24.87 |
| Revenue Growth | ★ 33.26 | N/A |
| 52 Week Low | $34.38 | $125.10 |
| 52 Week High | $64.05 | $228.29 |
Technical Indicators
Market Signals| Indicator | ONON | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 67.72 | 63.04 |
| Support Level | $45.83 | $178.80 |
| Resistance Level | $48.16 | $188.99 |
| Average True Range (ATR) | 1.70 | 7.47 |
| MACD | 0.50 | 1.51 |
| Stochastic Oscillator | 87.60 | 91.62 |
Price Performance
Historical ComparisonAbout ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.